To further evaluate the anti-tumor efficacy of CD276 Dash CAR-T on pancreatic cancer in physiological environment, we constructed a NOG mouse xenograft model with subcutaneous injection of Capan-1 cells. This evidence concerns the gene CD276 and pancreatic neoplasm.